Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › More Patients with Optimal Glycemic Control after Participation in a CSII-specific Education Program (INPUT) : Results from a Randomized Controlled Trial

Publication

More Patients with Optimal Glycemic Control after Participation in a CSII-specific Education Program (INPUT) : Results from a Randomized Controlled Trial

Kulzer, Bernhard; Ehrmann, Dominic; Schipfer, Melanie; u. a. (2020): More Patients with Optimal Glycemic Control after Participation in a CSII-specific Education Program (INPUT) : Results from a Randomized Controlled Trial, in: Bamberg: Otto-Friedrich-Universität, doi: 10.20378/irb-47105.

Details

Faculty/Chair
Faculty/Professorship
Author
Schipfer, Melanie
Lippmann-Grob, Bernhard
Haak, Thomas
Corporate Body
ADA 78th Scientific Sessions, 78, 2018, Orlando, Florida, USA
Publisher Information
Otto-Friedrich-Universität : Bamberg
Year of publication
2020
Pages
1
Source/Other editions
Diabetes : the journal of the American Diabetes Association. 67 (2018), Supplement 1, S. A176 (671-P). - ISSN: 0012-1797
Year of first publication
2018
Language
English
DOI
Licence
URN
Abstract

Despite the technological advances of CSII-therapy, many patients with CSII-therapy do not achieve optimal glycemic control. We developed an education program for CSII-therapy (INPUT) and evaluated its efficacy in a randomized controlled trial with a six-month follow-up. INPUT addresses the specific knowledge and skills to effectively handle CSII-therapy as well as possible psychological barriers.

We analyzed whether participation in the INPUT program increased the number of patients with optimal glycemic control (HbA1c < 7.5%).

254 patients with CSII-therapy were randomized to either receive the INPUT education program or treatment-as-usual and assessed at follow-up. All patients were already performing CSII-therapy for 8.7 ± 6.8 years, with a mean diabetes duration of 23.1 ± 12.6 years. HbA1c at baseline was 8.3 ± 0.9%. Optimal glycemic control at baseline was achieved by 13% in the INPUT group and 20% in the control group.

Logistic regression with group as independent factor controlling for optimal glycemic control at baseline was performed. Dependent variable was optimal glycemic control at the six-month followup.

Group was a significant predictor with INPUT patients having a 2-fold higher chance to achieve optimal glycemic control (OR = 1.98; 95% CI 1.04 – 3.78; p = 0.037) compared to patients in the control group. At follow-up, 27% of the INPUT group had achieved optimal glycemic control while only 18 % in the control group.

In this study, patients performed CSII-therapy for almost 10 years without achieving optimal glycemic control. After participation in INPUT, patient more often achieved optimal glycemic control compared to a treatment-as-usual control group. Thus, the INPUT education program was effective in improving glycemic control in patients with long-standing diabetes. Considering the higher costs of CSII-therapy, this beneficial effect of the education program has health-economic implications.

GND Keywords
Diabetologie
Patientenschulung
DDC Classification
150 Psychology
RVK Classification
YC 6800
YC 6400
Type
Conferenceobject
URI
Activation date
2020-02-11

Permalink: https://fis.uni-bamberg.de/handle/uniba/47105 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.